Jun 26, 2026
6:5
For every 5 shares held, investors received 6. The price per share adjusted from $26.21 to $21.84.
The split itself did not change the total investment value.
Zhejiang Dayang Biotech Group Co., Ltd. Class A (SZSE:003017) operates in the Chemicals: major diversified industry.
Zhejiang Dayang Biotech Group Co., Ltd. Class A company overviewZhejiang Dayang Biotech Group Co., Ltd. Class A's most recent stock split was on June 26, 2026. It was a 6-for-5 forward split, so shareholders received 6 shares for every 5 they held.
Zhejiang Dayang Biotech Group Co., Ltd. Class A (SZSE:003017) has split its stock 2 times: a 7-for-5 split on November 14, 2023 and a 6-for-5 split on June 26, 2026.
Zhejiang Dayang Biotech Group Co., Ltd. Class A has split its stock 2 times. This history records 2 forward splits between November 14, 2023 and June 26, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Zhejiang Dayang Biotech Group Co., Ltd. Class A's 6-for-5 split on June 26, 2026, every 5 shares became 6 shares.
Zhejiang Dayang Biotech Group Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on June 26, 2026, less than a year ago. Companies announce splits in advance, and any new SZSE:003017 split will appear on this page.
Already premium?